Edwards Lifesciences Corporation
US ˙ NYSE ˙ US28176E1082

SecurityEW / Edwards Lifesciences Corporation
InstitutionRitholtz Wealth Management
Latest Disclosed Ownership3,221 shares
Latest Disclosed Value $ 257,910
Ritholtz Wealth Management reports 13.67% decrease in ownership of EW / Edwards Lifesciences Corporation

On April 20, 2026 - Ritholtz Wealth Management filed a 13F-HR form disclosing ownership of 3,221 shares of Edwards Lifesciences Corporation (US:EW) valued at $257,938 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 23, 2026 disclosing 3,731 shares of Edwards Lifesciences Corporation. This represents a change in shares of -13.67% during the quarter. The current value of the position is $277,006 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-20 2026-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 3,221 -510 -13.67 258 -19.18 0.0045
2026-01-23 2025-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 3,731 3,731 318 0.0058
2025-10-28 2025-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 0 -2,590 -100.00 0 -100.00
2025-07-28 2025-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 2,590 2,590 203 0.0045
2024-10-10 2024-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 0 -2,807 -100.00 0 -100.00
2024-08-01 2024-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 2,807 58 2.11 259 -1.15 0.0086
2024-04-24 2024-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,749 96 3.62 263 29.70 0.0091
2024-01-18 2023-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,653 2,653 202 0.0078
2023-10-13 2023-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 0 -3,030 -100.00 0 -100.00
2023-07-17 2023-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 3,030 170 5.94 286 20.76 0.0129
2023-04-20 2023-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,860 2,860 237 0.0118
2023-01-19 2022-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 0 -11,057 -100.00 0 -100.00
2022-10-19 2022-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 11,057 7,696 228.98 914 185.63 0.0485
2022-07-15 2022-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 3,361 813 31.91 320 6.67 0.0202
2022-04-14 2022-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,548 370 16.99 300 6.38 0.0203
2022-01-18 2021-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,178 2,178 282 0.0175
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.